Dr. James Beck Discusses FDA Approval of RYTARY for Parkinson #39;s Disease
On Thursday, January 8, RYTARY, an extended release formulation of carbidopa/levodopa, was approved by the US Food and Drug Administration (FDA) for the treatment of Parkinson #39;s disease. The...
By:
parkinsonsdiseasefdnContinue reading here:
Dr. James Beck Discusses FDA Approval of RYTARY for Parkinson's Disease - Video
Recommendation and review posted by Fredricko
